✦ LIBER ✦

Samarium-153 EDTMP kit formulation for therapy of disseminated bone cancer

✍ Scribed by P. Sorby; J.G. Wilson; J.H. Turner

Book ID: 102370098
Publisher: John Wiley and Sons
Year: 1989
Tongue: French
Weight: 150 KB
Volume: 26
Category: Article
ISSN: 0022-2135
DOI: 10.1002/jlcr.25802601211

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

[153Sm]EDTMP: A potential therapy for bo

[153Sm]EDTMP: A potential therapy for bone cancer pain

✍ Richard A. Holmes 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 633 KB

Formulation of 99mTc-Sn-EDTMP: Freeze-Dr

Formulation of 99mTc-Sn-EDTMP: Freeze-Dried Kit for Bone Scanning

✍ A Mushtaq 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Samarium-153-Lexidronam complex for trea

Samarium-153-Lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer

✍ Oliver Sartor; Robert H Reid; Peter J Hoskin; Donald P Quick; Peter J Ell; Rober 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Clinical benefit of bone-targeted radiom

Clinical benefit of bone-targeted radiometabolic therapy with153Sm-EDTMP combined with chemotherapy in patients with metastatic hormone-refractory prostate cancer

✍ Sergio Ricci; Giuseppe Boni; Ilaria Pastina; Dario Genovesi; Claudia Cianci; Ser 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 160 KB

Some radiation protection problems conne

Some radiation protection problems connected with the use of186Re-HEDP and153Sm-EDTMP for palliative therapy of bone metastases

✍ V. Hušák; M. Mysliveček 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 266 KB

Efficacy of samarium 153 and strontium 8

Efficacy of samarium 153 and strontium 89 treatment for bone metastases in prostate cancer patients: monotherapy vs. treatment combined with external beam radiotherapy. Preliminary report

✍ Maciej Bączyk; Piotr Milecki; Piotr Martenka; Jerzy Sowiński 📂 Article 📅 2007 🏛 Wielkopolskie Centrum Onkologii 🌐 Polish ⚖ 96 KB

## Background Approximately 60-80% of metastatic prostate cancer patients suffer from pain caused by bone metastases. Bone metastases have a negative impact on patient performance status.